Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
Guardado en:
Autores principales: | K Pukite, I Urtane, I Pupkevica, I Cernevska, O Boicuka, J Meisters, D Straupmane, A Strelnieks, A Lejnieks, O Kalejs |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f2e624fdd12419f86347496224f5138 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AF in Cancer Patients: A Different Need for Anticoagulation?
por: Ana Pardo Sanz, et al.
Publicado: (2019) -
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Mahmoud Abdelnabi, et al.
Publicado: (2020) -
New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method
por: Ali Çoner
Publicado: (2021) -
New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method
por: Mustafa Arıcı, et al.
Publicado: (2021) -
Direct-acting Anticoagulants in Chronic Coronary Syndromes
por: Emmanuel Sorbets, et al.
Publicado: (2020)